The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
Clinical trial NCT03667014 · COMPLETED
Trial details
- NCT number
- NCT03667014
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2022-12-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.